Molecular epidemiology: principles and practices. Schulte PA, Perera FP, eds. San Diego, CA: Academic Press, 1993 Apr; :547-564
Link
NIOSHTIC No.
00232201
Abstract
The possibility of using biological markers for early diagnosis of musculoskeletal disorders was discussed. Incorporating biomarkers into epidemiological studies of musculoskeletal disorders was considered. It was noted that very little effort has been made to identify and use biomarkers for diagnosing musculoskeletal disorders. Many aspects of epidemiological studies could be improved by incorporating validated biomarkers since the occupational risk factors for most musculoskeletal disorders have been identified. Repetitive forceful movements of the wrist, for example, have been identified as a risk factor for carpal tunnel syndrome. Developing a marker of the biologically effective dose, in this case the amount of trauma necessary to cause early musculoskeletal changes, would allow more accurate studies of the relationship between complex exposures such as segmented vibrations or repetitive work and disease outcome. Considerations for incorporating biomarkers into epidemiological studies of musculoskeletal disorders were discussed. An important consideration is deciding what type of tissue sample should be obtained. Specific types of biomarkers that can be used for detecting early musculoskeletal changes were reviewed. These include proteins that are constituents of musculoskeletal tissue and are produced through catabolic or repair processes, proteins associated with inflammatory changes, and indicators of immune or autoimmune processes. Application of these biomarkers to osteoarthrosis, low back pain, cumulative trauma disorders, and other musculoskeletal disorders was considered. Techniques for measuring biomarkers were summarized. Using animal models for investigating musculoskeletal biomarkers was discussed.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.